muscle loss glp 1 Do GLP-1 drugs shrink your muscles? New study explains the risks and what to do Glucagon-like peptide-1 receptor agonists and
Description
The study "Liraglutide versus placebo as an adjunct to glucose-lowering therapy in patients with type 2 diabetes and moderate renal failure" (LIRA-RENAL) did not demonstrate a benefit of liraglutide in lowering eGFR, although the duration of the study (26 weeks) may have been insufficient to show an effect

Pharmacol Rev 2016;68:9541013.ArticlePubMedPMC 30

It is important to consult a licensed healthcare professional if you experience: Severe, persistent abdominal pain that does not go away

This kind of risk reduction is a very big deal for the millions of Americans who are overweight and already living with heart disease
